LANGE LOUIS G

Average Profitability
8.67%
Insider Buys Quantity
2
Insider Buys Sum
$492,992.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of LANGE LOUIS G

According to the SEC Form 4 filings, LANGE LOUIS G, being in a position of

  1. director at NewAmsterdam Pharma Company N.V.,
    оver the last 12 months, has bought 5000 shares for $95,000, and sold 0 shares,
    over all time since 2024-02-13, has bought 5000 shares for $95,000, and sold 0 shares.

The largest purchase of all time was on 2013-07-01 and amounted to 28428 shares of Esperion Therapeutics, Inc. for $397,992.

Biography of LANGE LOUIS G

No biography is available at this moment.

2024-02-13PurchaseNewAmsterdam Pharma Company N.V.
NAMS
director
5,000
0.0052%
$19.00$95,000-2.55%
2013-07-01PurchaseEsperion Therapeutics, Inc.
ESPR
director
28,428
0.1852%
$14.00$397,992+8.67%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.